A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

作者：C. Manegold, Nico van Zandwijk, A. Szczęsna, Petr Zatloukal, Joseph S. K. Au, Maria Błasińska-Morawiec, Piotr Serwatowski, Maciej Jerzy Krzakowski, Jacek Jassem, E.H. Tan, Rebecca J. Benner, Antonella Ingrosso, Sandra J. Meech, David Readett, N. M. Thatcher · 发表于：Annals of Oncology · 年份：2011 · DOI：10.1093/annonc/mdr030 · 被引用次数：128 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Lung Cancer Diagnosis and Treatment